Ardelyx reported $139.53M in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
Abbott USD 50.83B 1.76B Jun/2025
Amgen USD 7.43B 1.22B Jun/2025
Ardelyx USD 139.53M 33.76M Jun/2025
Corcept Therapeutics USD 635.79M 47.49M Jun/2025
Life Technologies USD 74.66M 4.64M Jun/2025
Sanofi 70.28B 7.58B Jun/2025
TG Therapeutics USD 276.43M 39.14M Jun/2025
United Therapeutics USD 7.17B 366.4M Jun/2025